Treatment of intrahepatic cholestatic diseases
AssigneeCymaBay Therapeutics, Inc.
InventorsPol Boudes, Charles A. McWherter
Life of this patent
Estimating the term…
Abstract
Treatment of intrahepatic cholestatic diseases by therapy with MBX-8025 or an MBX-8025 salt.
Claims9
A method of treating primary sclerosing cholangitis by administering to a subject in need thereof a therapeutically effective amount of (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)-phenoxy)propyl)thio)-2-methylphenoxy)acetic acid or a salt thereof.
“A method of treating primary sclerosing cholangitis by orally administering to a subject in need thereof a therapeutically effective amount of (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)-phenoxy)propyl)thio)-2-methylphenoxy)acetic acid L-Lysine dihydrate salt.
Dependencies are inferred from the claim text.